Table 2 The results of reverse MR analysis of ARDS and lipids. (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001)
From: Causal relationship between lipidome and acute respiratory distress syndrome
Traits | Outcome | SNPs | Method | b | se | p− value | OR (95% CI) |
|---|---|---|---|---|---|---|---|
Cholesterol | GCST90277257 | 28 | MR Egger | 0.2899 | 0.1131 | 0.0165* | 1.3363 (1.0704–1.6683) |
Weighted median | 0.2541 | 0.0567 | 7.5881 × 10− 6**** | 1.2894 (1.1536–1.4412) | |||
Inverse variance weighted | 0.2268 | 0.0488 | 3.3351 × 10− 6**** | 1.2546 (1.1402–1.3806) | |||
Simple mode | 0.2831 | 0.1175 | 0.0230* | 1.3273 (1.0541–1.6712) | |||
Weighted mode | 0.2831 | 0.1091 | 0.0151* | 1.3273 (1.0716–1.6439) | |||
Phosphatidylcholine (14:0_16:0) | GCST90277272 | 28 | MR Egger | − 0.1363 | 0.1226 | 0.2764 | 0.8725 (0.6861–1.1096) |
Weighted median | − 0.0581 | 0.0647 | 0.3687 | 0.9435 (0.8311–1.0710) | |||
Inverse variance weighted | − 0.0178 | 0.0539 | 0.7412 | 0.9823 (0.8838–1.0918) | |||
Simple mode | − 0.1233 | 0.1134 | 0.2868 | 0.8839 (0.7076–1.1041) | |||
Weighted mode | − 0.1157 | 0.1048 | 0.2793 | 0.8907 (0.7252–1.0938) | |||
Phosphatidylcholine (16:0_20:5) | GCST90277288 | 28 | MR Egger | 0.1628 | 0.3127 | 0.6070 | 1.1768 (0.6375–2.1722) |
Weighted median | 0.4127 | 0.0599 | 5.6037 × 10− 12**** | 1.5109 (1.3435–1.6991) | |||
Inverse variance weighted | 0.6216 | 0.1404 | 9.6071 × 10− 6**** | 1.8620 (1.4139–2.4522) | |||
Simple mode | 0.5570 | 0.1194 | 7.5325 × 10− 5**** | 1.7455 (1.3811–2.2061) | |||
Weighted mode | 0.5399 | 0.1084 | 3.2078 × 10− 5**** | 1.7159 (1.3874–2.1221) | |||
Phosphatidylcholine (18:0_18:2) | GCST90277300 | 28 | MR Egger | 0.1993 | 0.2701 | 0.4673 | 1.2205 (0.7187–2.0726) |
Weighted median | 0.0092 | 0.0544 | 0.8644 | 1.0093 (0.9071–1.1230) | |||
Inverse variance weighted | − 0.0423 | 0.1177 | 0.7190 | 0.9585 (0.7609–1.2074) | |||
Simple mode | − 0.0275 | 0.1056 | 0.7960 | 0.9728 (0.7909–1.1965) | |||
Weighted mode | − 0.0028 | 0.0982 | 0.9769 | 0.9971 (0.8225–1.2087) | |||
Phosphatidylethanolamine (18:1_18:1) | GCST90277349 | 28 | MR Egger | − 0.0497 | 0.2910 | 0.8656 | 0.9515 (0.5378–1.6832) |
Weighted median | 0.0020 | 0.0585 | 0.9716 | 1.0020 (0.8935–1.1238) | |||
Inverse variance weighted | 0.0090 | 0.1247 | 0.9421 | 1.0090 (0.7901–1.2886) | |||
Simple mode | 0.0516 | 0.1077 | 0.6353 | 1.0530 (0.8525–1.3006) | |||
Weighted mode | 0.0318 | 0.1136 | 0.7816 | 1.0323 (0.8262–1.2898) | |||
Triacylglycerol (51:2) | GCST90277393 | 28 | MR Egger | 0.4669 | 0.1917 | 0.0220* | 1.5950 (1.0954–2.3226) |
Weighted median | 0.1906 | 0.0627 | 0.0023** | 1.2100 (1.0700− 1.3684) | |||
Inverse variance weighted | 0.2957 | 0.0835 | 0.0003*** | 1.3440 (1.1411–1.5831) | |||
Simple mode | 0.1843 | 0.1059 | 0.0931 | 1.2024 (0.9769− 1.4800) | |||
Weighted mode | 0.1680 | 0.0988 | 0.1003 | 1.1830 (0.9747–1.4358) | |||
Triacylglycerol (52:4) | GCST90277398 | 28 | MR Egger | 0.7768 | 0.2001 | 0.0006*** | 2.1745 (1.4690–3.2189) |
Weighted median | 0.3664 | 0.0618 | 3.1784 × 10− 9**** | 1.4425 (1.2777–1.6285) | |||
Inverse variance weighted | 0.5341 | 0.0885 | 1.6484 × 10− 9**** | 1.7059 (1.4340–2.0293) | |||
Simple mode | 0.3786 | 0.1072 | 0.0015** | 1.4602 (1.1834–1.8018) | |||
Weighted mode | 0.3675 | 0.1036 | 0.0014** | 1.4441 (1.1787–1.7693) | |||
Triacylglycerol (54:3) | GCST90277404 | 28 | MR Egger | 0.6220 | 0.2472 | 0.0183* | 1.8628 (1.1473–3.0245) |
Weighted median | 0.3105 | 0.0621 | 5.7923 × 10− 7**** | 1.3641 (1.2077–1.5407) | |||
Inverse variance weighted | 0.3771 | 0.1082 | 0.0004*** | 1.4581 (1.1793–1.8028) | |||
Simple mode | 0.3632 | 0.1035 | 0.0016** | 1.4379 (1.1738–1.7615) | |||
Weighted mode | 0.2484 | 0.0988 | 0.0182* | 1.2819 (1.0562–1.5560) |